SELECTION :
- Difficulties associated with the interpretation of postmortem toxicology. Stephenson L., Van Den Heuvel C., Scott T., Byard R.W., p. 405-412.
- Ethyl acetate in e-liquids: Implications for breath testing. Holt A.K., Veeser A.M., Poklis J.L., Peace M.R., p. 413-418.
- LC-MS-MS method for mitragynine and 7-hydroxymitragynine in hair and its application in authentic hair samples of suspected kratom abusers. Rhee J., Shin I., Kim J., Lee J., Cho B., Kim J., et al., p. 429-438.
- Cross-reactivity of 24 cannabinoids and metabolites in blood using the Immunalysis Cannabinoids Direct enzyme-linked immunosorbent assay. Patton A.L., Pacheco I.C., Seither J.Z., Brown J.T., Walterscheid J.P., Karschner E.L., p. 439-446.
- A two-year review of cocaine findings in impaired driving investigations in Ontario, Canada. Currie Z., Lamparter C., Gosselin S., Watterson J., p. 447-455.
- Enantiomeric profile of amphetamines in seized drug samples and in blood of impaired drivers in Iceland: The rise of (R)-methamphetamine? Bauer A.E., Jakobsdottir M.R., Olafsdottir K., p. 456-462.
- Using forensic intelligence as a model for determining future toxicology methods: TBI forensic toxicology and forensic drug chemistry nitazene identification. Gray A., Douglas S., Tiller M., Bleakley M., p. 463-467.
- Evaluation of the ARK Diagnostics immunoassay for qualitative detection of xylazine in urine. Kyle P.B., Mattiello C.J., Hua A., Toohey J.M., Korn W.R., Saldana-Reed A., et al., p. 468-471.